Yasutaka Mochizuka
Overview
Explore the profile of Yasutaka Mochizuka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enomoto N, Nakai S, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, et al.
Respir Res
. 2024 Sep;
25(1):346.
PMID: 39342309
Background: Interstitial pneumonia with autoimmune features (IPAF), which does not meet any of the criteria for connective tissue diseases (CTD), has been attracting an attention in patients with idiopathic interstitial...
2.
Watanabe H, Inoue Y, Karayama M, Yazawa S, Mochizuka Y, Yasui H, et al.
JCO Precis Oncol
. 2024 Apr;
8:e2300538.
PMID: 38662982
Purpose: Understanding the function of BRAF mutants is crucial for determining the best treatment strategy. This study aimed to characterize a rare variant, , which was identified in a patient...
3.
Enomoto N, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, Naoi H, et al.
Respir Med
. 2024 Feb;
224:107577.
PMID: 38408707
Background: Patients with idiopathic interstitial pneumonia (IIP) have a favourable prognosis when they have interstitial pneumonia with autoimmune features (IPAF). However, precise IPAF-related findings from high-resolution computed tomography (HRCT) and...
4.
Mochizuka Y, Enomoto N, Daisuke A, Inoue Y, Yasui H, Hozumi H, et al.
Am J Respir Crit Care Med
. 2023 Oct;
209(1):e1-e3.
PMID: 37788379
No abstract available.
5.
Kono M, Oshima Y, Katsumata M, Hirama R, Takeda K, Mochizuka Y, et al.
Intern Med
. 2023 May;
63(1):119-124.
PMID: 37225487
A 48-year-old woman was admitted to our hospital with acute respiratory failure. Chest computed tomography showed ground-glass opacity and patchy emphysematous lesions in both lungs. Corticosteroid therapy was effective; however,...
6.
Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, et al.
Respirology
. 2023 May;
28(8):775-783.
PMID: 37221050
Background And Objective: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested that IPF progression may negatively affect nutritional status. Weight loss...
7.
Takeda K, Miwa H, Kono M, Hirama R, Oshima Y, Mochizuka Y, et al.
Respir Med Case Rep
. 2023 Mar;
42:101824.
PMID: 36910019
A 75-year-old woman was admitted to our hospital with progressive dyspnea 7 months after second-line treatment with pembrolizumab for advanced non-small cell lung cancer. Chest radiography revealed hyperinflation in both...
8.
Enomoto N, Naoi H, Mochizuka Y, Isayama T, Tanaka Y, Fukada A, et al.
BMC Pulm Med
. 2022 Oct;
22(1):387.
PMID: 36289542
Background: Acute exacerbation (AE) of systemic autoimmune disease-related interstitial lung diseases (SAID-ILD) is less common than AE of idiopathic pulmonary fibrosis (IPF) and the details of AE-SAID-ILD have not been...
9.
Mochizuka Y, Fujisawa T, Inoue Y, Hozumi H, Suzuki Y, Karayama M, et al.
Respir Med Case Rep
. 2022 Mar;
37:101632.
PMID: 35309972
We report herein a case of trimethoprim-sulfamethoxazole (TMP-SMX) induced eosinophilic pneumonia in a 27-year-old woman with radiological features of bilateral nonsegmental airspace consolidation resembling cryptogenic organizing pneumonia at the peripheral...
10.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, et al.
Respir Investig
. 2021 Oct;
60(1):158-161.
PMID: 34649811
Background: Combination therapy with dexamethasone, remdesivir, and baricitinib has become a promising treatment for moderate or severe COVID-19; however, we have observed transient leukocytopenia in COVID-19 patients who received combination...